No Cover Image

Journal article 669 views 119 downloads

Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints

Sabina Halappanavar, Penny Nymark, Harald F. Krug, Martin Clift Orcid Logo, Barbara Rothen‐Rutishauser, Ulla Vogel

Small, Volume: 17, Issue: 15, Start page: 2007628

Swansea University Author: Martin Clift Orcid Logo

  • 56250.pdf

    PDF | Version of Record

    This is an open access article under the terms of the Creative Commons Attribution License

    Download (2.28MB)

Check full text

DOI (Published version): 10.1002/smll.202007628

Published in: Small
ISSN: 1613-6810 1613-6829
Published: Wiley 2021
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa56250
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2021-02-14T14:38:51Z
last_indexed 2021-05-29T03:20:33Z
id cronfa56250
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-05-28T19:21:09.7670337</datestamp><bib-version>v2</bib-version><id>56250</id><entry>2021-02-14</entry><title>Non&#x2010;Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints</title><swanseaauthors><author><sid>71bf49b157691e541950f5c3f49c9169</sid><ORCID>0000-0001-6133-3368</ORCID><firstname>Martin</firstname><surname>Clift</surname><name>Martin Clift</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-02-14</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Small</journal><volume>17</volume><journalNumber>15</journalNumber><paginationStart>2007628</paginationStart><paginationEnd/><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1613-6810</issnPrint><issnElectronic>1613-6829</issnElectronic><keywords>in vitro toxicity; lung fibrosis; nanoparticles; nanotoxicity; risk assessment</keywords><publishedDay>15</publishedDay><publishedMonth>4</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-04-15</publishedDate><doi>10.1002/smll.202007628</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-05-28T19:21:09.7670337</lastEdited><Created>2021-02-14T14:35:12.2021472</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Sabina</firstname><surname>Halappanavar</surname><order>1</order></author><author><firstname>Penny</firstname><surname>Nymark</surname><order>2</order></author><author><firstname>Harald F.</firstname><surname>Krug</surname><order>3</order></author><author><firstname>Martin</firstname><surname>Clift</surname><orcid>0000-0001-6133-3368</orcid><order>4</order></author><author><firstname>Barbara</firstname><surname>Rothen&#x2010;Rutishauser</surname><order>5</order></author><author><firstname>Ulla</firstname><surname>Vogel</surname><order>6</order></author></authors><documents><document><filename>56250__19388__a67d73c284ab418c8ffbe4532dc8438d.pdf</filename><originalFilename>56250.pdf</originalFilename><uploaded>2021-02-26T16:47:13.1658165</uploaded><type>Output</type><contentLength>2387850</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>This is an open access article under the terms of the Creative Commons Attribution License</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2021-05-28T19:21:09.7670337 v2 56250 2021-02-14 Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints 71bf49b157691e541950f5c3f49c9169 0000-0001-6133-3368 Martin Clift Martin Clift true false 2021-02-14 BMS Journal Article Small 17 15 2007628 Wiley 1613-6810 1613-6829 in vitro toxicity; lung fibrosis; nanoparticles; nanotoxicity; risk assessment 15 4 2021 2021-04-15 10.1002/smll.202007628 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2021-05-28T19:21:09.7670337 2021-02-14T14:35:12.2021472 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Sabina Halappanavar 1 Penny Nymark 2 Harald F. Krug 3 Martin Clift 0000-0001-6133-3368 4 Barbara Rothen‐Rutishauser 5 Ulla Vogel 6 56250__19388__a67d73c284ab418c8ffbe4532dc8438d.pdf 56250.pdf 2021-02-26T16:47:13.1658165 Output 2387850 application/pdf Version of Record true This is an open access article under the terms of the Creative Commons Attribution License true eng http://creativecommons.org/licenses/by/4.0/
title Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
spellingShingle Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
Martin Clift
title_short Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
title_full Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
title_fullStr Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
title_full_unstemmed Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
title_sort Non‐Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints
author_id_str_mv 71bf49b157691e541950f5c3f49c9169
author_id_fullname_str_mv 71bf49b157691e541950f5c3f49c9169_***_Martin Clift
author Martin Clift
author2 Sabina Halappanavar
Penny Nymark
Harald F. Krug
Martin Clift
Barbara Rothen‐Rutishauser
Ulla Vogel
format Journal article
container_title Small
container_volume 17
container_issue 15
container_start_page 2007628
publishDate 2021
institution Swansea University
issn 1613-6810
1613-6829
doi_str_mv 10.1002/smll.202007628
publisher Wiley
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2021-04-15T04:11:04Z
_version_ 1763753763045113856
score 11.037056

Similar Items